Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ANGIODYNAMICS INCANGO · Entity 5275 | Director | July 14, 2020 | July 16, 2020 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ANGIODYNAMICS INC
Report date July 14, 2020 · Filed July 16, 2020
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 77,504 |
Reported balance
After 2020-07-14 transaction · row 1
1 source rowRow 1 · 2020-07-14 · Grant · Acquired 15,323 · Balance 77,504 F1: The acquisition of 15,323 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 15,323 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/14/2021. |
Filing footnotes · ownership attribution and instrument terms
F1: The acquisition of 15,323 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 15,323 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/14/2021.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 14, 2020 Filed Jul 16, 2020 23:06 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 15,323 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-20-013365 · doc1.xml · nonDerivative · entry 1 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,504 F1 · shares: The acquisition of 15,323 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 15,323 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/14/2021. Read SEC document |
| July 17, 2019 Filed Jul 20, 2019 01:18 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,057 | $0.00 | $0.00 |
DisclosureSEC source: 0001567619-19-015031 · doc1.xml · nonDerivative · entry 1 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,181 F1 · shares: The acquisition of 7,057 shares of common stock ("Common Stock") of AngioDynamics, Inc., represents 7,057 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/17/2020. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 20:12 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 7,000 | $0.00 Strike: $11.92 | $0.00 |
DisclosureSEC source: 0001567619-19-014983 · doc1.xml · derivative · entry 5 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,000 shares Expires 2020-08-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options for 25% of the shares each became exercisable on 08/06/2014, 08/06/2015, 08/06/2016 and 08/06/2017, respectively. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 20:12 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 6,650 | $0.00 Strike: $10.68 | $0.00 |
DisclosureSEC source: 0001567619-19-014983 · doc1.xml · derivative · entry 4 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 6,650 shares Expires 2019-08-07 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for 25% of the shares each became exercisable on 08/07/2013, 08/07/2014, 08/07/2015 and 08/07/2016, respectively. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 20:12 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | SaleCommon Stock | 13,650 | $21.45 | $292,792.50 |
DisclosureSEC source: 0001567619-19-014983 · doc1.xml · nonDerivative · entry 3 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,124 Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 20:12 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 7,000 | $11.92 | $83,440.00 |
DisclosureSEC source: 0001567619-19-014983 · doc1.xml · nonDerivative · entry 2 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 16, 2019 Filed Jul 18, 2019 20:12 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 6,650 | $10.68 | $71,022.00 |
DisclosureSEC source: 0001567619-19-014983 · doc1.xml · nonDerivative · entry 1 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 61,774 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 18, 2018 Filed Jul 21, 2018 01:23 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 6,307 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-18-033081 · doc1.xml · nonDerivative · entry 1 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,124 F1 · shares: The acquisition of 6,307 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 6,307 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/18/2019. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 19:24 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $13.53 | $0.00 |
DisclosureSEC source: 0001140361-17-035496 · doc1.xml · derivative · entry 6 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 14,000 shares Expires 2018-08-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Options for one-third of the shares each became exercisable on 08/03/2012, 08/03/2013 and 08/03/2014, respectively. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 19:24 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $14.31 | $0.00 |
DisclosureSEC source: 0001140361-17-035496 · doc1.xml · derivative · entry 5 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 25,000 shares Expires 2017-10-19 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: Options for one-third of the shares each became exercisable on 10/19/2011, 10/19/2012 and 10/19/2013, respectively. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 19:24 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 10,471 | $18.09 | $189,420.39 |
DisclosureSEC source: 0001140361-17-035496 · doc1.xml · nonDerivative · entry 4 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 48,817 Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 19:24 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 14,000 | $13.53 | $189,420.00 |
DisclosureSEC source: 0001140361-17-035496 · doc1.xml · nonDerivative · entry 3 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 59,288 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 19:24 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Tax withholdingCommon Stock | 19,776 | $18.09 | $357,747.84 |
DisclosureSEC source: 0001140361-17-035496 · doc1.xml · nonDerivative · entry 2 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,288 Read SEC document |
| September 12, 2017 Filed Sep 14, 2017 19:24 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | Exercise / conversionCommon Stock | 25,000 | $14.31 | $357,750.00 |
DisclosureSEC source: 0001140361-17-035496 · doc1.xml · nonDerivative · entry 1 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,064 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| July 26, 2017 Filed Jul 28, 2017 19:33 UTC | ANGIODYNAMICS INC ANGO · Entity 5275 | GrantCommon Stock | 7,976 | $0.00 | $0.00 |
DisclosureSEC source: 0001140361-17-029104 · doc1.xml · nonDerivative · entry 1 Gould Kevin J · CIK 0001504093 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,064 F1 · shares: The acquisition of 7,976 shares of common stock ("Common Stock") of AngioDynamics, Inc. represents 7,976 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. The restricted stock units vest on 07/26/2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.